Tagomics Wins NHS Grant, Unveils De-Methylation Platform for Early Cancer Testing with Rob Neely, CSO
Jul 01, 2025•5 min
Episode description
This is a free preview of a paid episode. To hear more, visit www.mendelspod.com
In this episode of Mendelspod, Theral sits down with Rob Neely, co-founder and CSO at Tagomics, to discuss how his company is fusing genomics, epigenomics, and fragmentomics into a single, assumption-free assay for early cancer detection. The conversation begins with breaking news: Tagomics has just received a new grant from the UK’s Innovation Agency a…
For the best experience, listen in Metacast app for iOS or Android
Open in Metacast